发明名称 COMBINATION OF RASAGILINE AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS, IN PARTICULAR HUNTINGTON'S DISEASE
摘要 <p>This invention provides a method of treating a patient afflicted with a neurodegenerative disorder, e.g., Huntington's disease, comprising administering to the patient rasagiline as an add-on therapy to or in combination with pridopidine. This invention also provides a package and a pharmaceutical composition comprising rasagiline and pridopidine for treating a patient afflicted with a neurodegenerative disorder. This invention also provides rasagiline for use as an add-on therapy or in combination with pridopidine in treating a patient afflicted with a neurodegenerative disorder. This invention further provides use of rasagiline and pridopidine in the preparation of a combination for treating a patient afflicted with a neurodegenerative disorder.</p>
申请公布号 CA2884260(A1) 申请公布日期 2014.04.03
申请号 CA20132884260 申请日期 2013.09.27
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD. 发明人 HAYDEN, MICHAEL;FITZER-ATTAS, CHERYL
分类号 A61K31/451;A61K31/137;A61K31/445 主分类号 A61K31/451
代理机构 代理人
主权项
地址